Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01858012 · ClinicalTrials.gov registry record
Insulin Resistance in HCV Infection
A clinical trial of Insulin Resistance, sponsored by University of California, San Francisco.
- Active
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT01858012: Active study of Insulin Resistance, sponsored by University of California, San Francisco.
NCT01858012 is a study of Insulin Resistance that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 250 participants, roughly in line with the 243-participant average among 120 other Insulin Resistance trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01858012, a study of Insulin Resistance, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The study hypothesis is that the means by which HCV induces glucose intolerance is through impairment of B-cell function and compensatory hyperinsulinemia in predisposed Latinos with insulin resistance and that HCV eradication improves these abnormalities. It is also hypothesized that moderate alcohol consumption impact insulin sensitivity and secretion with Latinos with or without HCV infection.
Primary Outcome
steady state plasma glucose level (mg/dL)
Conditions Studied
Interventions
- BEHAVIORAL Moderate alcohol cessation
Study Locations (1)
California
- University of california San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2008-01-01 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT01858012 still lists
NCT01858012 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 243-participant average among 120 other Insulin Resistance trials with a reported enrollment target.
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Moderate alcohol cessation is the first listed.
NCT01858012 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01858012 about?
NCT01858012 is a clinical study titled "Insulin Resistance in HCV Infection". The study hypothesis is that the means by which HCV induces glucose intolerance is through impairment of B-cell function and compensatory hyperinsulinemia in predisposed Latinos with insulin resistance and that HCV eradication improves these abnormalities. It is also hypothesized that moderate alcoh...
What is the current status of trial NCT01858012?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2008-01-01. Estimated completion is 2026-12-31.
What conditions does trial NCT01858012 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT01858012?
The interventions under investigation include: Moderate alcohol cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01858012?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01858012 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01858012's enrollment target sits among peer trials
250 8th of 120 higher than 112 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI